TITLE

A FEW CONSIDERATIONS AT THE END OF THE A H1N1 INFLUENZA PANDEMIC IN IASI COUNTY

PUB. DATE
November 2010
SOURCE
Romanian Journal of Infectious Diseases;2010, Vol. 13 Issue 4, p219
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
57736338

 

Related Articles

  • Number of swine flu patients going into intensive care rises. Siva, Nayanah // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;11/7/2009, Vol. 339 Issue 7729, p1048 

    The article reports on the continued increase in the number of patients diagnosed with swine flu who were admitted to intensive care in England. For the week ended October 28, 2009, hospitalized patients with swine flu increased by 63 percent from July 2009. According to chief medical officer...

  • Just do the swine flu tests, why can't you.  // New Scientist;6/6/2009, Vol. 202 Issue 2711, p5 

    The author asserts that the spread of swine flu in Europe is due to the failure of testing people without symptoms. He cites the many reasons why countries do not test their entire population, including the forced use of antiviral medicines on mild strains and a lack of basic understanding of...

  • Effect of Vaccines and Antivirals during the Major 2009 A(H1N1) Pandemic Wave in Norway - And the Influence of Vaccination Timing. de Blasio, Birgitte Freiesleben; Iversen, Bj�rn G.; Tomba, Gianpaolo Scalia // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    To evaluate the impact of mass vaccination with adjuvanted vaccines (eventually 40% population coverage) and antivirals during the 2009 influenza pandemic in Norway, we fitted an age-structured SEIR model using data on vaccinations and sales of antivirals in 2009/10 in Norway to Norwegian ILI...

  • Effect of Vaccines and Antivirals during the Major 2009 A(H1N1) Pandemic Wave in Norway - And the Influence of Vaccination Timing. de Blasio, Birgitte Freiesleben; Iversen, Bjørn G.; Tomba, Gianpaolo Scalia // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    To evaluate the impact of mass vaccination with adjuvanted vaccines (eventually 40% population coverage) and antivirals during the 2009 influenza pandemic in Norway, we fitted an age-structured SEIR model using data on vaccinations and sales of antivirals in 2009/10 in Norway to Norwegian ILI...

  • High H1N1 prevalence and mortality rates a concern. Janukavicius, Patrick // CMAJ: Canadian Medical Association Journal;2/18/2014, Vol. 186 Issue 3, pE104 

    The article discusses the higher than anticipated mortality rate of type A (H1N1) influenza, the most common flu virus in Canada, in 2014. According to Dr. Pierre Lebel, an infectious disease specialist, there were ten confirmed deaths in Alberta attributed to type A (H1N1) influenza. He adds...

  • Withholding flu drugs from seniors a new discussion item.  // Long-Term Living: For the Continuing Care Professional;Sep2009, Vol. 58 Issue 9, p10 

    The article reports on the suggestion of researchers from Italy's Bruno Kessler Foundation that the elderly should be the last in line to receive swine flu drugs. According to the researchers, giving antiviral drugs to older people would not decrease mortality and may even increase resistance....

  • Influenza Pandemic Waves under Various Mitigation Strategies with 2009 H1N1 as a Case Study. Ghosh, Suma; Heffernan, Jane // PLoS ONE;2010, Vol. 5 Issue 12, p1 

    A significant feature of influenza pandemics is multiple waves of morbidity and mortality over a few months or years. The size of these successive waves depends on intervention strategies including antivirals and vaccination, as well as the effects of immunity gained from previous infection....

  • 2009H1N1 Influenza in Immunocompetent and Immunocompromised Patients. Moss, Ronald B. // Infectious Diseases: Research & Treatment;2012, Issue 5, p33 

    The treatment and prevention of influenza virus infection has been associated with two major challenges that are exemplified by 2009H1N1 as well as previous pandemics. The constant evolutionary pressure on the influenza virus can result in novel strains which may not be optimally protected by...

  • Perfil epidemiológico de la mortalidad por influenza humana A (H1N1) en México. Fajardo-Dolci, Germán E.; Hernández-Torres, Francisco; Santacruz-Varela, Javier; Rodríguez-Suárez, Javier; Lamy, Philippe; Arboleya-Casanova, Heberto; Gutiérrez-Vega, Rafael; Manuell-Lee, Gabriel; Córdova-Villalobos, José Ángel // Salud Pública de México;sep2009, Vol. 51 Issue 5, p361 

    Objective. To carry out the epidemiological analysis of 122 influenza A (H1N1) deaths confirmed by laboratory and help to improve the diagnosis and timely managing of cases. Material and Methods. A total of 122 clinical records were analyzed of patients with confirmed influenza A (H1N1) virus...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics